Skip to main content

Table 4 MRAs. For abbreviations, dimensions and use of log data see text, Tables 1, 2a, 2b, APPI, III, Figure 2

From: Idiopathic recurrent calcium urolithiasis (IRCU): pathophysiology evaluated in light of oxidative metabolism, without and with variation of several biomarkers in fasting urine and plasma - a comparison of stone-free and -bearing male patients, emphasizing mineral, acid-base, blood pressure and protein status

   

SF

  

SB

  

SF+SB

  

Blocks +

Outcomes

Influential +++, ®

N*

R 2 **

p***

N

R 2

P

N

R 2

P

"Acid-

U-pH

1, 2, 4, 6

77

0.30

< 0.001

75

0.0

0.58

152

0.08

0.02

Base"

B-HC03 -

4, 5

79

0.16

< 0.001

75

0.0

0.50

154

0.06

0.006

"Blood pressure

D-BP

2, 4, 6

44

0.04

0.19

56

0.21

0.002

100

0.13

< 0.001

Uric acid"

P-UA

2, 4, 4, 7

52

0.05

0.17

65

0.23

< 0.001

117

0.15

< 0.001

"Protien"

PNP

1, 2, 3, 4, 5

52

0.15

0.03

65

0.15

0.01

117

0.14

0.007

 

UNP/PNP

5, 6

75

0.09

0.01

73

0.10

0.01

148

0.11

< 0.001

"Calcium"

PM ++

6, 7, 8

50

0.22

0.002

63

0.07

0.06

113

0.07

0.01

 

UM/PM

1, 2, 3, 4, 5

75

0.59

< 0.001

73

0.58

< 0.001

148

0.55

< 0.001

 

UM/PM

1, 3, 4, 5, 6 ®

61

0.45

< 0.001

62

0.16

0.01

123

0.29

< 0.001

  1. +: IRCU area under study (see APP III): ++: synonymous P-Ca/P-Pi: +++ : position in the respective block of APP III; ®: panels 1 - 6 in Figure 2;
  2. *: number of Paired observations; ** fraction of the model (= 1.0), adjusted for confounder; ***: level of signification of the model; dashed regions: degree of outcome prediction in SB deviates from SF patients.